HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial

BACKGROUND: Observational and laboratory studies suggest that some hormonal contraceptive methods, particularly intramuscular depot medroxyprogesterone acetate (DMPA-IM), might increase women's susceptibility to HIV acquisition. We aimed to compare DMPA-IM, a copper intrauterine device (IUD), a...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675739/
https://www.ncbi.nlm.nih.gov/pubmed/31204114
http://dx.doi.org/10.1016/S0140-6736(19)31288-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675739/
https://www.ncbi.nlm.nih.gov/pubmed/31204114
http://dx.doi.org/10.1016/S0140-6736(19)31288-7

Ejemplares similares